ASX Earnings Divergence: Zurich Moves for ClearView as Genetic Signatures Struggles
ClearView Wealth has entered a definitive acquisition agreement with Zurich following a period of strong profit growth, while Genetic Signatures faces a critical restructuring phase to address unsustainable cash burn.